跳至主要内容
临床试验/JPRN-jRCT2080223462
JPRN-jRCT2080223462已完成1 期

An adaptive Phase I/II study to assess safety, efficacy, pharmacokinetics and pharmacodynamics of RO7112689 in healthy volunteers and patients with paroxysmal nocturnal hemoglobinuria (PNH)

CHUGAI PHARMACEUTICAL CO., LTD.0 个研究点目标入组 44 人开始时间: 2017年2月17日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
44

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 18age old 至 <= 75age old(—)
性别
All

入选标准

  • Male or female patients between the age of 18 and 75 years
  • -A documented GPI-deficient PNH clone size of >= 10%
  • -PNH patients who have not been treated with any complement inhibitor or if previously treated stopped treatment due to lack of efficacy based on a single missense C5 heterozygous mutation (Part 2, 4)
  • -Patients receive regular infusions of eculizumab (Part 3, 4)

排除标准

  • -Known or suspected hereditary complement deficiency.
  • -History of meningococcal meningitis.
  • -Evidence of moderate to severe concurrent renal, liver, cardiac, pulmonary or gastrointestinal disease not related to PNH as determined by the Investigator.
  • -History of bone marrow transplantation.

研究者

相似试验

进行中(未招募)
1 期
A Study to Assess Safety, Effectiveness, Pharmacokinetics, and Pharmacodynamics of RO7112689 in Healthy Volunteers and Patients With Paroxysmal Nocturnal HemoglobinuriaParoxysmal nocturnal hemoglobinuria (PNH)MedDRA version: 19.0Level: LLTClassification code 10055629Term: Paroxysmal nocturnal hemoglobinuriaSystem Organ Class: 100000004857
EUCTR2016-002128-10-HUF. Hoffmann-La Roche Ltd49
进行中(未招募)
1 期
A Study to Assess Safety, Effectiveness, Pharmacokinetics, and Pharmacodynamics of RO7112689 in Healthy Volunteers and Patients With Paroxysmal Nocturnal HemoglobinuriaParoxysmal nocturnal hemoglobinuria (PNH)MedDRA version: 21.1Level: LLTClassification code 10055629Term: Paroxysmal nocturnal hemoglobinuriaSystem Organ Class: 100000004857
EUCTR2016-002128-10-DEF. Hoffmann-La Roche Ltd49
进行中(未招募)
1 期
Studio volto a valutare la sicurezza, l’efficacia, la farmacocinetica e la farmacodinamica di RO7112689 in volontari sani e in pazienti con Emoglobinuria Parossistica NotturnaParoxysmal nocturnal hemoglobinuria (PNH)MedDRA version: 20.1Level: LLTClassification code 10055629Term: Paroxysmal nocturnal hemoglobinuriaSystem Organ Class: 100000004857
EUCTR2016-002128-10-ITF. HOFFMANN - LA ROCHE LTD.49
进行中(未招募)
1 期
A Study to Assess Safety, Effectiveness, Pharmacokinetics, and Pharmacodynamics of RO7112689 in Healthy Volunteers and Patients With Paroxysmal Nocturnal HemoglobinuriaParoxysmal nocturnal hemoglobinuria (PNH)MedDRA version: 19.0Level: LLTClassification code 10055629Term: Paroxysmal nocturnal hemoglobinuriaSystem Organ Class: 100000004857
EUCTR2016-002128-10-NLF. Hoffmann-La Roche Ltd74
进行中(未招募)
1 期
A Study to Assess Safety, Effectiveness, Pharmacokinetics, and Pharmacodynamics of RO7112689 in Healthy Volunteers and Patients With Paroxysmal Nocturnal HemoglobinuriaParoxysmal nocturnal hemoglobinuria (PNH)MedDRA version: 20.0Level: LLTClassification code 10055629Term: Paroxysmal nocturnal hemoglobinuriaSystem Organ Class: 100000012950
EUCTR2016-002128-10-FRF. Hoffmann-La Roche Ltd49
An adaptive Phase I/II study of RO7112689 in healthy... | 临床试验